2
Clinical Trials associated with Grass allergen immunotherapy(Karolinska Institutet)Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice (CHOICE) in JAPAN - CHOICE-JAPAN
Start Date28 Oct 2022 |
Sponsor / Collaborator- |
Is Intralymphatic Allergen Immunotherapy Effective and Safe: a Human Randomized Clinical Trial- Substudy Borås With a Randomized Preseasonal Booster
15 patients with moderate to severe allergic rhinitis against grass were recruited and enrolled in the study. They received three open label intralympatic grass allergen injections with the dose 1000 SQ-U each and with one month interval. The next year the patients were randomized double blind to an active or placebo booster injection of 1000 SQ-U before the pollen season. Grass specific IgG4 levels were measured before and at various time ponts after treatment.
Start Date25 Apr 2014 |
Sponsor / Collaborator- |
100 Clinical Results associated with Grass allergen immunotherapy(Karolinska Institutet)
100 Translational Medicine associated with Grass allergen immunotherapy(Karolinska Institutet)
100 Patents (Medical) associated with Grass allergen immunotherapy(Karolinska Institutet)
100 Deals associated with Grass allergen immunotherapy(Karolinska Institutet)